If you have just worked out that you have rosacea, it can be very confusing to know where to start with treatment. A recently published paper will be serve as a great resource to take to your doctor to help with treatments. Rosacea: Time for a New Approach was sponsored by Galderma, and contains references to the latest information about new treatments (except for the just-released Oxymetazoline based Rhofade).
Download the full PDF Here: Rosacea- Time for a New Approach print a copy and take it to your doctor. Also see the online version here.
Rosacea: Time for a New Approach, Forum for Nord Derm Ven 2017, Vol. 22, No. 1, CARSTEN SAUER MIKKELSEN, PETER BJERRING, MARGARETA LIRVALL, MARGARETA SVENSSON, HELENE RINGE HOLMGREN, ALEXANDER SALAVA AND THEIS HULDT-NYSTRØM
Time for a new approach?
The classification and subtyping of rosacea has, until now, been based on a subset of symptoms and clinical findings. More than 50% of rosacea patients have a combination of dif- ferent subtypes, which shows that subtyping is inadequate and has limitations both for research and selection of treatment.
The use of a phenotype approach will allow a more accurate and stringent classification of rosacea. New diagnostic tools emerge, and transcriptome analysis has revealed a possible distinct gene profile for each subtype of rosacea. A change in paradigm towards a phenotype classification, which can also easily be combined with newer diagnostic methods, such as transcriptome analysis, is an interesting possibility. The use of more objective criteria will allow those aspects that are most troubling to patients to be better targeted and allow the best treatment to be selected
